Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
J Clin Oncol. 2024 Apr 1;42(10):1158-1168. doi: 10.1200/JCO.23.00943. Epub 2024 Jan 12.
J Clin Oncol. 2024.
PMID: 38215358
Clinical Trial.
Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens for breast cancer.
Gilbar P, Sorour N, McPherson I.
Gilbar P, et al.
Support Care Cancer. 2015 Mar;23(3):619-20. doi: 10.1007/s00520-015-2608-x. Epub 2015 Jan 11.
Support Care Cancer. 2015.
PMID: 25577506
No abstract available.
Item in Clipboard
Cite
Cite